MITO

Stealth BioTherapeutics Corp. ADS

Delisted

MITO was delisted on the 15th of November, 2022.

10 hedge funds and large institutions have $947K invested in Stealth BioTherapeutics Corp. ADS in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+5
Holders Change %
+100%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
PM
1
Prosight Management
Texas
$417K +$417K +336,167 New
BBHC
2
Brown Brothers Harriman & Co
New York
$217K
Renaissance Technologies
3
Renaissance Technologies
New York
$158K +$158K +127,800 New
IC
4
Ikarian Capital
Texas
$47K
Millennium Management
5
Millennium Management
New York
$45K +$45K +36,030 New
PC
6
PA Capital
Virginia
$28K +$28K +22,461 New
Two Sigma Investments
7
Two Sigma Investments
New York
$15K +$15K +12,434 New
Deutsche Bank
8
Deutsche Bank
Germany
$12K +$12K +9,800 New
Morgan Stanley
9
Morgan Stanley
New York
$7K -$5.83K -5,000 -45%
UBS Group
10
UBS Group
Switzerland
$1K -$16.5K -6,600 -94%